Fidelio Capital

About The Fund

Fidelio Capital is a Swedish investment company established in 2010 and headquartered in Stockholm, Sweden, with an additional office in London, United Kingdom. The firm concentrates on investing in non-public companies across Northern Europe, focusing mainly on industries such as Software (including Web Marketplace, SaaS, etc.), BioTech, Food & Beverage, and Medical Devices (& Hospital Services). They have a clear preference for acquiring majority ownership in portfolio companies, which is part of their strategy to influence operations, drive growth, and ensure they can control the exit process. As an active investor, Fidelio Capital collaborates closely with management teams, providing support and working diligently to help businesses reach their full potential. Their investment approach is characterized by a combination of creativity and determination, and they aim to transform innovative ideas into successful market leaders. Fidelio Capital's portfolio showcases a significant level of activity and accomplishment, with over 200 investments to date, 1,800+ million EUR in total revenue from portfolio companies, and an impressive average yearly sales growth of 50% for these entities. The founder and CEO, Gabriel Fitzgerald, underscores the firm's challenge to envision the world two decades ahead and to identify and back companies that promise an extraordinary future. An extraordinary team drives success, and Fidelio prioritizes recruiting top-tier talent to continue their track record of achievement. Their recent news includes strategic acquisitions and expansion efforts, such as Avima's integration into the iBinder group, Vimian Group's entry into the veterinary dental market with the purchase of 'iM3', and KEYTO Group's acquisition of 'Fastighetstvtt i Ume AB' through its subsidiary Servly. This illustrates Fidelio Capital's ongoing commitment to advancing its companies and shaping future industry leaders globally.